Table 1: Descriptive statistics.

 

Study groups

 

Demographic data

Patients
(n = 74)

Control
(n = 74)

Z/χ2

p

 

Age (year)

Mean ± SD

57.1 ± 19.6

(19-98)

52 ± 14.6

(19-86)

-1.928

0.054

Med (IQR)

58.5 (27.5)

54.5 (15)

  Sex n (%)

 

0.027

0.869

Female

 

35 (%50.7)

34 (%49.3)

Male

 

39 (%49.3)

40 (%50.7)

Descriptive characteristics of the patient group

Med (IQR)

Age (years)

57.1 ± 19.6 (19-98)

58.5 (27.5)

Sex n (%)

Female 35 (50.7%)

 

Male 39 (49.3%)

 

Etiological factors n (%)

Biliary

37 (50)

Alcohol

14 (18.9)

Other factors

23 (31.1)

 

Mean ± SD (min-max)

  Med (IQR)

Vitals

Systolic blood pressure (mmHg)

122.7 ± 25.6 (60-198)

120 (32)

Diastolic blood pressure (mmHg)

69.1 ± 17.1 (40-130)

65 (20)

Peak heartbeat (/min)

100.1 ± 18.7 (65-155)

100 (25)

Axillary body temperature (°C)

36.9 ± 0.7 (35-39)

37 (0.8)

Respiratory rate (/min)

14.9 ± 2.9 (11-25)

14.5 (5)

Laboratory values

WBC (103/uL)

12.3 ± 4.8 (2.7-28)

12 (8)

Neu (103/uL)

9.4 ± 4.9 (0.6-26)

8.4 (6)

Lym (103/uL)

2.2 ± 2.2 (0.1-13.7)

1.6 (1.5)

Neu/Lym

9.1 ± 11.7 (0.64-66)

4.5(9.3)

CRP (mg/dl)

6.9 ± 5 (0.2-19)

6 (6.1)

ALT (U/L)

142.3 ± 191.3 (9-1028)

61 (146.5)

AST (U/L)

139.6 ± 186.5 (10.7-24)

74 (122.8)

Total bilirubin (mg/dl)

2.5 ± 2.2 (0.2-9.4)

1.7 (2.9)

Direct bilirubin (mg/dl)

1.5 ± 1.7 (0.1-9)

0.8 (1.7)

Calcium (mg/dl)

8.9 ± 0.7 (7.4-10.6)

9 (1)

LDH (U/L)

428.9 ± 279.2 (140-2000)

379 (236)

pH

7.4 ± 0.1 (7.1-7.98)

7.4 (0.1)

HCO3 (mEq/L)

21.5 ± 3.8 (8-29)

22 (4)

Amylase (U/L)

1071.7 ± 1067.9 (32-4571)

717 (1239.8)

Lipase (U/L)

2236.4 ± 2652.4 (38-12358)

1011 (2481.5)

Mortality n (%) 12 (16.2)

             

SD: Standard Deviation; Med: Median; IQR: Interquartile Range other Factors Hyperlipidemia. Hypercalcemia. Drugs. Toxins. Infections